2022-09-03 | NDAQ: BPMC | Press release

New York, New York–(Newsfile Corp. – September 3, 2022) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Blueprint Medicines Corporation (NASDAQ: BPMC) arising from allegations that Blueprint Medicines could have provided misleading business information to the investing public.

SO WHAT: If you have purchased titles from Blueprint Medicines, you may be entitled to compensation without payment of out-of-pocket fees or out-of-pocket costs through a contingency fee arrangement. The law firm Rosen is preparing a class action lawsuit seeking to recover the losses of the investors.

WHAT TO DO NEXT: To join the potential class action, go to https://rosenlegal.com/submit-form/?case_id=8186 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information.

WHAT DOES IT TALK ABOUT: On August 17, 2022, before trading hours, Blueprint Medicines announced topline results from Part 2 of its PIONEER clinical trial of AYVAKIT.® (avapritinib) in patients with non-advanced systemic mastocytosis (SM). The results showed a deterioration in absolute improvement in symptom score from 15.6 points in this most recent trial to 19.7 in phase 1.

On this news, Blueprint Medicine’s stock price fell $7.38 per share, or 10%, to close at $61.17 per share on August 17, 2022, on unusually high trading volume.

WHY THE ROSEN LAW: We encourage investors to select qualified attorneys with proven track records in leadership roles. Often, companies issuing reviews do not have comparable experience, resources, or significant peer recognition. Be wise in choosing lawyers. Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder derivative litigation. Rosen Law Firm has reached the largest securities class action settlement against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has ranked in the top 4 every year since 2013 and has recovered hundreds of million dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Lawyer advertisement. Previous results do not guarantee a similar result.

——————————-

Contact information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, Pennsylvania

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/135905

Luisa D. Fuller